What is the recommended dosing schedule for naproxen, including adult and pediatric doses and adjustments for renal or hepatic impairment?

Naproxen Dosing

For adults, naproxen is dosed at 250-500 mg twice daily for chronic inflammatory conditions, or 500 mg initially followed by 250-500 mg every 6-12 hours for acute pain, with a maximum daily dose of 1000-1250 mg depending on the indication. 1

Adult Dosing by Indication

Chronic Inflammatory Conditions (Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis)

• Standard dose: 250 mg, 375 mg, or 500 mg twice daily 1
• High-dose therapy: May increase to 1500 mg/day for up to 6 months when higher anti-inflammatory activity is required, though this carries increased risk 1
• Morning and evening doses need not be equal 1

Acute Pain, Dysmenorrhea, Tendonitis, Bursitis

• Initial dose: 500 mg, followed by 500 mg every 12 hours OR 250 mg every 6-8 hours 1
• Maximum initial daily dose: 1250 mg 1
• Maximum maintenance dose: 1000 mg/day thereafter 1
• For acute conditions, naproxen sodium formulations are preferred due to more rapid absorption 1

Acute Gout

• Initial dose: 750 mg, followed by 250 mg every 8 hours until attack subsides 1

Migraine

• Dose: 275-550 mg every 2-6 hours 2
• Maximum initial dose: 825 mg 2
• Maximum daily dose: 1500 mg 2

Pediatric Dosing

Juvenile Arthritis (Age ≥2 years)

• Dose: Approximately 10 mg/kg/day in 2 divided doses (5 mg/kg twice daily) 1
• Use naproxen oral suspension rather than tablets for accurate dosing 1
• Maximum daily dose: 15 mg/kg/day for other pediatric conditions 1

Safety note: Not established for children under 2 years of age 1

Special Population Adjustments

Renal Impairment

• Moderate to severe renal impairment (CrCl <30 mL/min): Naproxen is not recommended 1
• Lower doses should be considered for mild renal impairment 1

Hepatic Impairment

• Lower doses should be considered 1
• Occasional transient abnormalities in liver function tests may occur but generally do not warrant immediate discontinuation 3

Elderly Patients

• Start with the lowest effective dose 1
• The unbound plasma fraction of naproxen increases in elderly patients despite unchanged total plasma concentration 1
• Dose adjustment may be required, particularly at higher doses 1
• Elderly patients are at greater risk for GI bleeding and renal toxicity 1

Important Clinical Considerations

Formulation Differences

Different formulations (tablets, suspension, delayed-release tablets, naproxen sodium) are not bioequivalent and have different pharmacokinetic profiles affecting onset of action 1. Consider this when switching formulations.

Onset of Action

Pain relief can begin within 1 hour 1

General Prescribing Principles

• Use the lowest effective dose for the shortest duration consistent with treatment goals 1
• Adjust dose based on clinical response and adverse events 1
• For long-term administration, a lower daily dose may suffice 1

Safety Monitoring

Common pitfalls to avoid:

• Exceeding maximum daily doses (increases cardiovascular and GI risks)
• Using in patients with CrCl <30 mL/min (contraindicated)
• Failing to reduce dose in elderly or those with mild renal/hepatic impairment
• Not considering formulation differences when switching products